DFS
Term · Oncology and biomedicine · MLC-T-ONC-002399
In cancer, the length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms of that cancer. In a clinical trial, measuring the DFS is one way to see how well a new treatment works. Also called disease-free survival, relapse-free survival, and RFS.
| Identifier | MLC-T-ONC-002399 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | disease-free survival; relapse-free survival |
| Synonyms | RFS |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002399",
"term": "DFS",
"field": "Oncology and biomedicine",
"definition": "In cancer, the length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms of that cancer. In a clinical trial, measuring the DFS is one way to see how well a new treatment works. Also called disease-free survival, relapse-free survival, and RFS.",
"expansions": [
"disease-free survival",
"relapse-free survival"
],
"synonyms": [
"RFS"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/dfs/"
}
Record 5,908 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.